Treatment to Prevent Hepatitis B Virus Reactivation in Patients With Lymphoma Receiving Chemotherapy

被引：2
|
作者：
Baang, Jihoon [1 ]
机构：
[1] Temple Univ, Dept Med, Sch Med, Philadelphia, PA 19140 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2015年 / 313卷 / 12期
关键词：
RESISTANCE; LAMIVUDINE; ENTECAVIR;
D O I：
10.1001/jama.2015.1438
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1269 / 1270
页数：2
相关论文
共 50 条
  • [31] Risk of hepatitis B virus reactivation during immunosuppressive treatment
    Kefeli, A.
    Tutkaoglu, S.
    Coskun, U. S.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (07) : 2823 - 2831
  • [32] Late reactivation of hepatitis B virus after rituximab-containing chemotherapy for mantle cell lymphoma: a case report
    Ciccullo, Arturo
    Ponziani, F. R.
    Maiolo, E.
    Pallavicini, F.
    Pompili, M.
    INFECTION, 2019, 47 (02) : 313 - 316
  • [33] The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab-based chemotherapy
    Lu, Shasha
    Xu, Yu
    Mu, Qitian
    Cao, Lihong
    Chen, Jian
    Zhu, Zhijuan
    Lou, Yinjun
    Meng, Haitao
    Qian, Wenbin
    Tong, Hongyan
    Mai, Wenyuan
    Huang, Jian
    Yu, Wenjuan
    Zhao, Xiaoying
    Jin, Jie
    LEUKEMIA & LYMPHOMA, 2015, 56 (04) : 1027 - 1032
  • [34] Successful treatment with lamivudine in two patients with severe reactivation of hepatitis B virus infection after withdrawal of chemotherapy
    Seksik, P
    Nahon, S
    Lesgourgues, B
    Cadranel, JF
    de Serre, NM
    Lenoble, M
    Lahmeck, P
    Charoud, A
    Delas, N
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2000, 24 (6-7): : 671 - 674
  • [35] Hepatitis B virus reactivation in adjuvant chemotherapy for breast cancer
    Ide, Yoshimi
    Ito, Yoshinori
    Takahashi, Shunji
    Tokudome, Nahomi
    Kobayashi, Kokoro
    Sugihara, Tsutomu
    Hattori, Masaya
    Yokoyama, Masahiro
    Uchiyama, Akira
    Inoue, Kazuaki
    Sakurai, Norio
    Hatake, Kiyohiko
    BREAST CANCER, 2013, 20 (04) : 367 - 370
  • [36] Entecavir as treatment for reactivation of hepatitis B in immunosuppressed patients
    Brost, Sylvia
    Schnitzler, Paul
    Stremmel, Wolfgang
    Eisenbach, Christoph
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (43) : 5447 - 5451
  • [37] Screening and Prevention of Hepatitis B Virus Reactivation During Chemotherapy
    Ludwig, Emmy
    Cohen, Nina
    Papanicolaou, Genovefa A.
    Seo, Susan K.
    ONCOLOGY-NEW YORK, 2015, 29 (12): : 937 - +
  • [38] Entecavir is an optional agent to prevent hepatitis B virus (HBV) reactivation: A review of 16 patients
    Watanabe, Masaaki
    Shibuya, Akitaka
    Takada, Juichi
    Tanaka, Yoshiaki
    Okuwaki, Yusuke
    Minamino, Tsutomu
    Hidaka, Hisashi
    Nakazawa, Takahide
    Koizumi, Wasaburo
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2010, 21 (04) : 333 - 337
  • [39] Hepatitis B Virus Screening and Potential Reactivation in Patients Undergoing Treatment for Cancer
    Hammond, Sarah P.
    Swaminathan, Sankar
    Bensinger, William I.
    Baden, Lindsey R.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2014, 12 (12): : 1655 - 1657
  • [40] Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphoma
    Tsutsumi, Y
    Tanaka, J
    Kawamura, T
    Miura, T
    Kanamori, H
    Obara, S
    Asaka, M
    Imamura, M
    Masauzi, N
    ANNALS OF HEMATOLOGY, 2004, 83 (01) : 58 - 60
12345